In addition, changes in FSP1 cellular membrane localization could significantly enhance the stability of FSP1 by preventing FSP1 protein degradation and therefore could inhibit ovarian cancer ferroptosis. This evidence concerns the gene AIFM2 and ovarian carcinoma.